Tao Wu

Tao Wu has extensive experience in the pharmaceutical industry. Tao served as an Associate Director of Clinical Science at Kaishi Pharmaceutical from 2019 to the present. Prior to this, they held various roles at Eli Lilly China, including Associate Director of Scientific Communication from 2018 to 2019, Senior Medical Communication Manager from 2016 to 2017, and Medical Communication Manager from 2014 to 2016.

Tao Wu completed a Bachelor's degree in Medicine and Surgery (M.B.B.S.) from Fudan University from 2001 to 2006. Following that, from 2008 to 2013, Tao Wu pursued a PhD in Immunology at The University of Connecticut Health Center.